Interstitial lung disease around the world

E-poster
Chairs: K. Moor (Rotterdam, Netherlands), M. Kreuter (Heidelberg, Germany)
Aims: This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.

Clusters of comorbidities in unclassifiable interstitial lung disease T. Prior (Aarhus, Denmark), C. Hyldgaard (Silkeborg, Denmark), S. Torrisi (Heidelberg, Germany), S. Kronborg-White (Aarhus, Denmark), C. Ganter (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany), E. Bendstrup (Aarhus, Denmark)
IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome J. Bordas-Martínez (barcelona, Spain), R. Gavaldà (barcelona, Spain), J. Shull (barcelona, Spain), v. Vicens-Zygmunt (barcelona, Spain), L. Planas-Cerezales (barcelona, Spain), G. Bermudo-Peloche (barcelona, Spain), S. Santos (barcelona, Spain), N. Salord (barcelona, Spain), C. Monasterio (barcelona, Spain), G. Suarez-Cuartin (barcelona, Spain), M. Molina-Molina (barcelona, Spain)
PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT S. Stornelli (Roma, Italy), D. Lacedonia (Roma, Italy), G. Scioscia (Roma, Italy), F. Simone (Roma, Italy), G. Lepore (Roma, Italy), R. Sabato (Roma, Italy), G. Giganti (Roma, Italy), G. Ciliberti (Roma, Italy), M. Foschino Barbaro (Roma, Italy)
All-cause mortality in an Idiopathic Pulmonary Fibrosis (IPF) cohort: retrospective analysis with cardiac QRISK-2 M. Watson (Cambridge, United Kingdom), T. McLellan (Cambridge, United Kingdom), M. Thillai (Cambridge, United Kingdom)
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)? M. Wijsenbeek (Rotterdam, Netherlands), P. Spagnolo (Padova, Italy), M. Kolb (Hamilton, Canada), M. Kreuter (Heidelberg , Germany), H. Nunes (Bobigny , France), W. Stansen (Ingelheim am Rhein, Germany), K. Rohr (, Ingelheim am Rhein, Germany), G. Inoue (Osaka, Japan)
Patient-reported outcomes in idiopathic pulmonary fibrosis; validity and reliability of visual analogue scales C. Moor (Rotterdam, Netherlands), R. Mostard (Heerlen, Netherlands), J. Grutters (Nieuwegein, Netherlands), P. Bresser (Amsterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands)
Validation of the SGRQ-I derived from SGRQ T. Prior (Aarhus, Denmark), N. Hoyer (Hellerup, Denmark), S. Burhan Shaker (Hellerup, Denmark), J. Rømhild Davidsen (Odense, Denmark), O. Hilberg (Vejle, Denmark), H. Patel (Mechelen, Belgium), E. Bendstrup (Aarhus, Denmark)
Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases. O. Moran Mendoza (Kingston (ON), Canada), S. Alyami (Riyad, Saudi Arabia), A. Moran-Macdonald (Kingston (ON), Canada), M. Kish (Kingston (ON), Canada), S. Davison (Toronto (ON), Canada)
PFBIO EXA: A prospective cohort of respiratory hospitalization in IPF patients. E. Åttingsberg (Copenhagen, Denmark), N. Hoyer (Copenhagen, Denmark), T. Prior (Aarhus , Denmark), E. Bendstrup (Aarhus, Denmark), S. Shaker (Copenhagen, Denmark)
Association between FVC and mortality or survival in idiopathic pulmonary fibrosis: a systematic literature review M. Molina Molina (Barcelona, Spain), E. Hart (Bethesda, United States of America), B. Lesher (Bethesda, United States of America), A. Ribera (Mechelen, Belgium), J. Langley (Mechelen, Belgium), H. Patel (Mechelen, Belgium)
Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study P. Faverio (Monza, Italy), A. Fumagalli (Monza, Italy), S. Conti (Monza, Italy), F. Madotto (Monza, Italy), S. Busnelli (Monza, Italy), F. Bini (Garbagnate Milanese, Italy), S. Harari (Milano, Italy), M. Mondoni (Milano, Italy), T. Oggionni (Pavia, Italy), E. Barisione (Genova, Italy), P. Ceruti (Brescia, Italy), C. Papetti (Garbagnate Milanese, Italy), A. De Laurentis (Garbagnate Milanese, Italy), A. Caminati (Milano, Italy), A. Valentino (Milano, Italy), S. Centanni (Milano, Italy), D. Noè (Milano, Italy), M. Della Zoppa (Pavia, Italy), S. Crotti (Pavia, Italy), M. Grosso (Genova, Italy), S. Sukkar (Genova, Italy), D. Modina (Brescia, Italy), M. Andreoli (Brescia, Italy), R. Nicali (Novara, Italy), G. Suigo (Busto Arsizio, Italy), F. De Giacomi (Monza, Italy), L. Mantovani (Monza, Italy), A. Pesci (Monza, Italy), F. Luppi (Monza, Italy)
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis M. Norestani (Copenhagen, Denmark)
Unclassifiable Interstitial Lung Disease (ILD). Why? E. De Freitas Gonzalez (León, Spain), C. López Garay (León, Spain), C. Menéndez Sánchez (León, Spain), C. Mier Bango (León, Spain), P. Franco Suárez (León, Spain), L. Sierra Herranz (León, Spain), E. Bollo De Miguel (León, Spain), J. Juan García (León, Spain), N. Alonso Orcajo (León, Spain), J. López Fernández (León, Spain), S. Fernández Huerga (León, Spain)
Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) A. Ramon (Sant Cugat del Vallés, Spain), E. Cano-Jiménez (Lugo, Spain), M. Rodríguez-Nieto (Madrid, Spain), A. Romero Ortiz (Granada, Spain), A. Villar (Granada, Spain), S. Armengol (Sant Cugat del Vallés, Spain), A. Julià (Barcelona, Spain), M. Morros (Barcelona, Spain)
Epidemiology of Idiopathic Pulmonary Fibrosis in Australia I. Cox (Hobart, Tasmania, Australia), P. Otahal (Hobart, Tasmania, Australia), B. De Graaff (Hobart, Tasmania, Australia), T. Corte (New South Wales, Australia), E. Walters (Hobart, Tasmania, Australia), A. Palmer (Hobart, Tasmania, Australia)
Frequency of observed interstitial lung disease in a secondary care hospital in the North West of England. S. Liew (Manchester (Greater Manchester), United Kingdom), C. Hayton (Manchester (Greater Manchester), United Kingdom), Z. Borrill (Manchester (Greater Manchester), United Kingdom), H. Law (Manchester (Greater Manchester), United Kingdom), G. Ng Man Kwong (Manchester (Greater Manchester), United Kingdom)
Association between severity of Idiopathic Pulmonary Fibrosis and air Pollution levels in Madrid P. Mariscal Aguilar (Madrid, Spain), L. Gómez Carrera (Madrid, Spain), E. Zamarrón De Lucas (Madrid, Spain), C. Carpio Segura (Madrid, Spain), M. Hidalgo Sánchez (Madrid, Spain), G. Bonilla Hernán (Madrid, Spain), M. Torres Sánchez (Madrid, Spain), M. Fernández-Velilla Peña (Madrid, Spain), P. Díaz-Agero Álvarez (Madrid, Spain), E. Villamañán Bueno (Madrid, Spain), R. Regojo Zapata (Madrid, Spain), C. Prados Sánchez (Madrid, Spain), R. Álvarez-Sala Walther (Madrid, Spain)
Association between mortality of Idiopathic Pulmonary Fibrosis and air Pollution levels in Madrid P. Mariscal Aguilar (Madrid, Spain), L. Gómez Carrera (Madrid, Spain), C. Carpio Segura (Madrid, Spain), E. Zamarrón De Lucas (Madrid, Spain), M. Hidalgo Sánchez (Madrid, Spain), G. Bonilla Hernán (Madrid, Spain), M. Torres Sánchez (Madrid, Spain), M. Fernández-Velilla Peña (Madrid, Spain), P. Díaz-Agero Álvarez (Madrid, Spain), E. Villamañán Bueno (Madrid, Spain), R. Regojo Zapata (Madrid, Spain), C. Prados Sánchez (Madrid, Spain), R. Álvarez-Sala Walther (Madrid, Spain)
Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis Y. Qiu (Princeton, United States of America), J. Zhu (Princeton, United States of America), B. Elpers (Princeton, United States of America), J. Jiang (Princeton, United States of America), A. Ogbomo (Plano, United States of America), R. Mallampati (Plano, United States of America), C. Byrne (Plano, United States of America), J. Tang (Plano, United States of America), A. Fischer (Princeton, United States of America)
Effect of sildenafil add-on to antifibrotic treatment in IPF patients J. Kang (Goyang, Republic of Korea), J. Song (Seoul, Republic of Korea)